Dimension
Overview
Dimension is a venture capital firm that invests in companies at the intersection of technology and life sciences, including biotechnology platforms, software infrastructure, and companies utilizing artificial intelligence and machine learning.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Chai Discovery | Jul 2026 | Series C | Co-investor |
| Enveda Biosciences | Sep 2026 | Series E | Co-investor |
| BioRender | Dec 2025 | VC Round | Lead |
| Earendil Labs | Mar 2026 | Series B | Lead |
| Aspect Biosystems | Jan 2025 | Series B | Lead |
For institutional investors. Book with your work email.
Key People
Adam Goulburn
Co-Founder
Zavain Dar
Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Dimension based?
Dimension is headquartered in New York City, New York, United States.
When was Dimension founded?
Dimension was founded in 2022.
How many portfolio companies does Dimension have?
Dimension has 7 portfolio companies in Caplight's dataset.
What are some companies in Dimension's portfolio?
Portfolio companies visible on Caplight include Chai Discovery, Enveda Biosciences, BioRender, Earendil Labs, Aspect Biosystems.
What was Dimension's most recent investment shown here?
Dimension's most recent investment in this portfolio sample was in Enveda Biosciences in 2026.
What sectors does Dimension focus on?
Dimension focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Enterprise Software, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does Dimension focus on?
Dimension typically invests at the Mid stage.
What is Dimension's AUM?
Dimension's assets under management are estimated between $850.0M and $850.0M.